Negative Pressure Wound Therapy (NPWT) : Principles and Applications

Slides:



Advertisements
Similar presentations
Green Wound Healing.
Advertisements

به نام خالق ماه.
There are three main steps in the process by which surgical wounds heal:  Inflammation – this lasts for a short time as the blood flow is increased to.
INDICATION FOR TOPICAL NEGATIVE PRESSURE THERAPY
SKIN INTEGRITY SHARON HARVEY 23/03/04. LEARNING OUTCOMES THE STUDENT SHOULD BE ABLE TO:- ILLUSTRATE THE STRUCTURE AND FUNCTION OF MAJOR COMPONENTS OF.
Brielle Bowyer & Preston Paynter
Wound Care Dressings and Their Uses
Best Practices for Pressure Ulcers to Promote Uncomplicated Healing.
CHRONIC WOUNDS Ann Moody TVN & Leg Ulcer Specialist Nurse NHS Cumbria.
Pressure Ulcer Management By Susan Yap, PT. Anatomy of the Skin Epidermis Dermis Subcutaneous Tissue Fascia Muscle Tendon and Bone.
Wounds and skin Ch /11/20152NRS /11/20153NRS
Susan E. Duffield, BSN, RN, CWOCN
Slides current until 2008 Diabetic neuropathy Wound healing.
Complex Wounds Management Adjuncts- Vacs, Flaps, and Ointments Evan S. Garfein, MD Director, Advanced Reconstructive Care (ARC) Program Director, Microsurgery.
Wound Assessment & Documentation
Vacuum Regulator Adapter Device For Wound Management System. Reconstructive Sciences Department, Health Campus, USM.
Positive Outcomes with Negative Pressure Wound Therapy Laurie S. Stelmaski BSN,RN,CWOCN.
Treatment of Radiation Burns Using a Novel Negative Pressure Wound Therapy System* with Minimal Adherence Bio-Dome TM Dressing Technology Patients presenting.
Determining Properties of Wound Dressings for Negative Pressure Wound Therapy Lora Aboulmouna, Lisa Lewicki, Ryan Frye.
Wound Care: Where do we go from here? Jesse M. Cantu, RN, BSN, CWS, FACCWS April 20, 2012 San Antonio, TX.
Wound care Jana Hermanova. Wound classification By cause – intentional, unintentional By cleanliness – clean, contaminated, infected By depth – superficial,
VENOUS STASIS ULCERS. Venous stasis ulcer: occurs from chronic deep vein insufficiency and stasis of blood in the venous system of the legs An open, necrotic.
Wound Healing System Development: V.A.C. Therapy Marybeth Jewell*, Melissa Kopacz*, Ian Sando*, Cary Berdy † Advisor: Dr. Naji Abumrad *Department of Biomedical.
WOUND CARE Wound Healing 1. inflammatory phase 2. proliferative or granulation phase 3. maturation, or wound remodeling, phase Inflammatory.
Health Science Technology
Skin Integrity and Wound Care
Chapter 48 Skin Integrity and Wound Care
The EPEC-O Curriculum is produced by the EPEC TM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong.
Wound Appearance Description Eschar
ASEPSIS SHARON HARVEY 28/7/05. ASEPSIS MEDICAL MEDICAL USED DURING DAILY ROUTINE CARE TO BREAK THE INFECTION CHAIN USED DURING DAILY ROUTINE CARE TO BREAK.
Chapter 8 Skin Integrity and Wound Care
Skin Integrity & Wound Care
Wound debridement Available methods for debridement Surgical Sharp Larval Enzymatic Autolytic Mechanical Chemical.
Wound Care Overview Carolyn Watts MSN,RN, CWON February 16, 2007.
Wounds and wound Care Pressure Ulcer Staging
Determining Properties of Wound Dressings for Negative Pressure Wound Therapy Lora Aboulmouna, Lisa Lewicki, Ryan Frye.
Suction pouching in neonate with a stoma -case study- Seonae Ryu, Yun Jin Lee, Jung- tak Oh, Seok Joo Han, Hye Kyung Chang Department of Pediatric Surgery,
Skin Integrity and Wound Care Management By. Responsibilities Identify patients “at-risk” for wound healing problems Initiate appropriate interventions.
Inflammation and Wound Healing Chapter 13 Overview Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Wound Care Chapter 5 Starts on page 100 Advanced Skills for Health Care Providers, Second Edition, Barbara Acello, 2007 Thompson Delmar.
ABSCESS PREVENTION AND MANAGEMENT. How can infections be prevented?  Encourage injecting in sites far from the abscess area (at least 12 inches away.
A fluid handling assessment of foam dressings Lovett J., Roberts S., Stephenson C. Introduction: Fluid controlling capabilities of advanced wound dressings.
Diabetic Foot. DM largest cause of neuropathy. Foot ulcerations is most common cause of hospital admissions for Diabetics. Expensive to treat, may lead.
Andy Passey September 23rd 2003 Advanced Wound Management in Europe: Market Overview and Critical Success Factors © 2003 Frost & Sullivan. All rights reserved.
Negative Pressure Wound Therapy (NPWT) : Principles and Applications A-Young Lee ( 李雅永 ) Academic support, Daewoong Pharmaceutical.
Global Negative Pressure Wound Therapy Market by Manufacturers, Countries, Type and Application, Forecast to WEBSITE Date:
DynaClose Delayed Primary Closure
HOW CAN Dressilk® IMPROVE SUPERFICIAL WOUND MANAGEMENT?
Effect of Negative Pressure Incision Care Dressing on wound infection rate in Colorectal Surgery: A Prospective Non Randomized Trial SM Zaidi, WM Chaudhry,
Bedsores (Decubitus Ulcers)
Patients & Methods 2012 December ~ 2013 December
Chapter 28 Wound Care.
Sumar RCD an effective ‘solution’ for: Managing heavy exudate
Chapter 28 Wound Care.
Databridgemarketresearch.comdatabridgemarketresearch.com US : UK :
Vacuum-assisted wound closure versus alginate for the treatment of deep perivascular wound infections in the groin after vascular surgery  Christina Monsen,
Chapter 28 Wound Care.
Wound Management for Primary Care Providers
DEBRIDEMENT Professor Donald G. MacLellan Executive Director
DB00102 Category : Angiogenesis Inducing Agents
Paul Berger, MD, Dennis de Bie, MaNP, Frans L
The patient underwent serial debridements and pleural cavity drainage.
Dressing Products Pat Sinasac CNC Wound / Stoma Management Subacute and Ambulatory Services 2014.
By: M. Rustom Plastic Surgeon
ACUTE COMPARTMENT SYNDROME
TEMPLATE Picture Picture Picture Picture Picture Picture Picture
Wound Care Market Wound Care Market.
Prevention of poststernotomy wound infections in obese patients by negative pressure wound therapy  Onnen Grauhan, MD, PhD, MBA, Artashes Navasardyan,
Paul Berger, MD, Dennis de Bie, MaNP, Frans L
Presentation transcript:

Negative Pressure Wound Therapy (NPWT) : Principles and Applications A-Young Lee (李雅永) Ph.D. Academic support, Daewoong Pharmaceutical

Ancient Cupping Therapy Ge Hong (281-341 A.D) “Acupuncture and cupping, more than half of the ills cured”

Evolution of NPWT Foam KulaVAC® -Daewoong 1995: Wound VAC®– KCI 1947, Russia Post-op exudate management Wall Suction & Gauze Foam KulaVAC® -Daewoong EZ Care™ - Smith & Nephew Engenex® (Boehringer Wound Systems) – ConvaTec Genadyne A4 – Genadyne Biotechnologies Inc. Kalypto - Kalypto Medical Medela® - Invia MoblVac® - Ohio Medical Prodigy™ - Premco Medical Systems, Inc. Prospera PRO-I™ & PRO-II™ Systems – Medica Renasys – Smith & Nephew Svedman™ & Sved™ Systems - Innovative Therapies Venturi™ System - Talley Group 1952 Closed suction used prophylactically to reduce Post-op complications

NPWT on Wound Healing Promotes Granulation tissue formation Provide moist wound environment Removes Exudate Infectious materials Mechanical/ Biological Forces Angiogenesis & ↑perfusion Cell migration & proliferation Promotes Granulation tissue formation

Composition of KulaVAC® Components Foam Dressing (Three Different Sizes) Film Dressing Accessories (Suction Head, Tubing with Connectors and Clamp)

Features of KulaVAC® Polyurethane Foam hydrophobic, prevents Contamination from exudate. Prevents ingrowth of granulation tissue Pore size : 400-600 μm

KulaVAC® Bridge

KulaVAC® Silver

2. The world’s first cyclic Mode of Curasys® Features of Curasys® 1. Portability Weight 890g Up to 12 hours of battery life A/C or battery operational 2. The world’s first cyclic Mode of Curasys® Increased vascular Perfusion Faster wound closure Reduced pain

KulaVAC® on Various Indications Dehisced Wound DM Foot Pressure Ulcer Trauma

KulaVAC® on Various Indications Skin Graft Open Abdomen Burn

KulaVAC® Publications

KulaVAC® Publications

KulaVAC® Publications Intermittent mode Cyclic mode

KulaVAC® Clinical Trial on Trauma Effects of Incisional NPWT on High-energy Foot & Ankle Trauma - A Prospective, Multicenter, Randomized Controlled Trial- High risk of Wound dehiscence, Marginal necrosis, Infection Infection/Dehiscence rate Pilon Fx: 5~40% Calcaneal Fx: 0~25% (본 연구는 CG Bio의 후원으로 이루어졌음.)